Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France

Sylvain Druais, Agathe Doutriaux, Magali Cognet, Annabelle Godet, Christophe Lançon (), Pierre Lévy, Ludovic Samalin and Pascal Guillon
Additional contact information
Christophe Lançon: Hôpitaux Sud - Département Universitaire de Psychiatrie - [Hôpital Sainte Marguerite - APHM] - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille - Hôpitaux Sud - Hôpital Sainte-Marguerite [CHU - APHM]
Pierre Lévy: LEDa - Laboratoire d'Economie de Dauphine - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres, Legos - Laboratoire d'Economie et de Gestion des Organisations de Santé - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres
Ludovic Samalin: NPsy-Sydo - Neuro-Psycho Pharmacologie des Systèmes Dopaminergiques sous-corticaux - CHU Clermont-Ferrand - UdA - Université d'Auvergne - Clermont-Ferrand I

Post-Print from HAL

Keywords: Cost-effectiveness; schizophrenia; Health Economics (search for similar items in EconPapers)
Date: 2016
References: Add references at CitEc
Citations:

Published in PharmacoEconomics, 2016, 34 (4), ⟨10.1007/s40273-015-0348-x⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01346623

DOI: 10.1007/s40273-015-0348-x

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().